Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children

Sarah Ronaldson,1 Matthew Taylor,1 Peter G Bech,2 Ruth Shenton,1 Albrecht Bufe3 1York Health Economics Consortium, York, UK; 2ALK-Abelló A/S, Hørsholm, Denmark; 3Ruhr-Universität Bochum, Bochum, Germany Background: Grass pollen-induced rhinoconjunctivitis is a common...

Full description

Bibliographic Details
Main Authors: Ronaldson S, Taylor M, Bech PG, Shenton R, Bufe A
Format: Article
Language:English
Published: Dove Medical Press 2014-04-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/economic-evaluation-of-sq-standardized-grass-allergy-immunotherapy-tab-a16384

Similar Items

Similar Items